Bionik Laboratories's basic earnings per share (Basic EPS) for the
three
months ended in Mar. 2023 was $-0.20.
Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2023 was $-0.72.
Bionik Laboratories's EPS without NRI for the
three
months ended in Mar. 2023 was $-0.20.
Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2023 was -0.72.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
Bionik Laboratories EPS (Basic) Historical Data
The historical data trend for Bionik Laboratories's EPS (Basic) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.
Bionik Laboratories's Basic EPS for the fiscal year that ended in Mar. 2023 is calculated as
EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.72
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Bionik Laboratories EPS (Basic) Related Terms
Thank you for viewing the detailed overview of Bionik Laboratories's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.
Bionik Laboratories (Bionik Laboratories) Business Description
Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and innovative robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BNKL has been successfully added to your 